Castle Biosciences CSTL
NASDAQ CSTL
$34.60 -0.39 (-1.10%)
As of: Sep 22, 2026 · 11:38 AM EDT

Castle Biosciences (CSTL) Non-Current Deffered Revenue (2018 - 2021)

Castle Biosciences' (CSTL) quarterly Non-Current Deffered Revenue came in at $986000.0 in Q3 2021, down 13.51% year-over-year from $1.1 million in Q3 2020, and up 2.39% quarter-over-quarter from $963000.0 in Q2 2021.

Analysis

Castle Biosciences (CSTL) Non-Current Deffered Revenue (2018 - 2021) Analysis & Trends

Castle Biosciences has disclosed Non-Current Deffered Revenue across 4 years of filings, most recently posting $986000.0 for Q3 2021.

  • In Q3 2021, Non-Current Deffered Revenue fell 13.51% year-over-year to $986000.0; the TTM figure through Sep 2021 stood at $986000.0 (down 13.51% YoY), while the FY2020 annual figure was $1.7 million, up 3054.55% from the prior year.
  • Non-Current Deffered Revenue came in at $986000.0 for Q3 2021 at Castle Biosciences, up from $963000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $1.7 million in Q4 2020 to a low of $44000.0 in Q4 2018.
  • Average Non-Current Deffered Revenue over 4 years is $638699.6, with a median of $941000.0 recorded in 2020.
  • Year-over-year, Non-Current Deffered Revenue jumped 3054.55% in 2020 and dropped 13.51% in 2021.
  • Over 4 years, Non-Current Deffered Revenue stood at $44000.0 in 2018, then gained by 25.0% to $55000.0 in 2019, then jumped by 3054.55% to $1.7 million in 2020, then plunged by 43.17% to $986000.0 in 2021.
  • Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $986000.0 in Q3 2021, $963000.0 in Q2 2021, and $995000.0 in Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 16.07 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn -
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn -
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn -
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 22.08 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn -
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 16.19 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 608,000.00
10 Castle Biosciences 1.08 Bn 811.36 Mn 79.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 986,000.00
Jun 30, 2021 963,000.00
Mar 31, 2021 995,000.00
Dec 31, 2020 1.74 Mn
Sep 30, 2020 1.14 Mn
Jun 30, 2020 941,000.00
Mar 31, 2020 54,000.00
Dec 31, 2019 55,000.00
Sep 30, 2019 56,006.00
Jun 30, 2019 56,690.00
Dec 31, 2018 44,000.00
API Access

Castle Biosciences Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CSTL&period=max&api_key=YOUR_API_KEY